Wound Care News

By Industry News

Toronto, Canada – July 7 2021 – MolecuLight Inc., the creator of a point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced the publication of an independent consensus study of 32 leading wound care clinicians in Diagnostics.

By Industry News

Jacksonville, FL. – June 28, 2021 – Next Science, a medical technology company and leader in treating biofilm-based infections in humans, today announced new educational broadcast content about chronic infections, which impact 17 million Americans each year. “The Balancing Act,” a lifestyle show that airs on the Lifetime channel, will feature a segment that discusses the costly and debilitating nature of these infections and how physicians can more effectively treat patients suffering from chronic wounds, including diabetic wounds, by using BLASTX, Next Science’s antimicrobial wound gel.

By Industry News

Toronto, Canada and Queensland, Australia – June 22, 2021 – MolecuLight Inc., the creator of a point-of-care fluorescence imaging device for detection of wounds containing elevated bacterial loads, announces it has signed LMT Surgical as its new Distributor in Australia and New Zealand. LMT, a provider of products and services to the medical market, will bring its comprehensive commercial capabilities to help meet the demand for the MolecuLight i:X to the wound care community in Australia and New Zealand.

By Industry News

Miami, FL – June 10, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue products, is launching a new awareness campaign that showcases the Amniox comprehensive family of human birth tissue-based products to facilitate wound healing and reduce associated cost of care. This year, Amniox commemorates ten years of improving patients’ lives by offering the natural potential of birth tissue products for surgical and wound applications to help expedite functional recovery.

By Industry News

In this update:

• Providing Expert Input to Noridian Draft Wound Care LCD
• Enhancing Transparency & Predictability of HCPCS Process
• Supporting Global Malnutrition Composite Score for Quality Measure Endorsement
• Shaping Hospital Outpatient CTP Payment Methodology
• Clarifying the Role of Commercial Policies in CMS Decisions About Coverage of Innovative Technology
• Launching New Members-Only Website Portal (Have You Set Up Your Login Yet?).
• And more…

By Industry News

The Wound Healing Foundation gave out a new record of 50 awards this year. Did you miss the ceremony? Here's what you missed.

By Industry News

Miami, FL – May 11, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech was awarded a group purchasing agreement with Premier, Inc. and The Resource Group on April 1, 2021. As such, members of both Group Purchasing Organizations (GPOs) can take advantage of pre-negotiated terms for Amniox human birth tissue products to support regenerative healing and functional recovery in surgical, chronic wound, and musculoskeletal applications.

By Industry News

Pittsburgh, PA and Toronto, ON – May 6, 2021 – MolecuLight, creator of a point-of-care fluorescence imaging device for real-time detection of bacteria in wounds, announced today that the company has partnered with Tissue Analytics, a Net Health company that provides software solutions for the wound care industry. The purpose of the partnership is to integrate the MolecuLight platform with Net Health’s Tissue Analytics application programming interface (API) program.

Industry News

May 4, 2021 – Pittsburgh, PA – MolecuLight Corp., creator of a point-of-care fluorescence imaging device for detection of wounds containing elevated bacterial loads, announces its MolecuLight i:X® fluorescence wound imaging device has received an Innovative Technology contract from Vizient, Inc., the nations’ largest member-driven health care performance improvement company. The new Innovative Technology contract for MolecuLight i:X signifies to Vizient members the device’s unique qualities that potentially bring improvement to the health care industry.

By Industry News

Sydney, Australia – Monday, April 26, 2021 – Next Science Limited is pleased to announce that it has received a section 510(k) clearance from the Food and Drug Administration (FDA) for the sale of XPERIENCE No Rinse Antimicrobial Solution as a medical device in the United States. Sales of XPERIENCE in the US will commence immediately.